# Administative Supplement: Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments

> **NIH NIH P01** · BOSTON CHILDREN'S HOSPITAL · 2020 · $105,710

## Abstract

Abstract
This attachment is not required for a Diversity Supplement application. Please refer to the
attachments uploaded to the “Other Attachments” section of this form as directed by NHLBI's
Research Supplement Application Guidelines

## Key facts

- **NIH application ID:** 10175780
- **Project number:** 3P01HL046925-23S1
- **Recipient organization:** BOSTON CHILDREN'S HOSPITAL
- **Principal Investigator:** Martha C. Sola-Visner
- **Activity code:** P01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $105,710
- **Award type:** 3
- **Project period:** 1992-07-01 → 2023-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10175780

## Citation

> US National Institutes of Health, RePORTER application 10175780, Administative Supplement: Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments (3P01HL046925-23S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10175780. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*